BIOTECH VC LUNCH & LEARN. SEPT. 29, 12-1pm @ Amistad 112. Christine Brennan, Principal at MRL Ventures Fund, will present to Yale faculty and researchers on key strategies for attracting investor interest. MRL Ventures Fund is Merck’s independent early-stage bio-therapeutics venture capital fund. **Lunch is included!** REGISTER HERE.
BLAVATNIK FUND INFO SESSION. OCT. 3, 1-1:30pm @ Park Street Auditorium (following Cancer Grand Rounds). Learn how to apply for up to $300,000 to move your innovative research to the marketplace! REGISTER HERE.
APPLICATION TIPS FROM BLAVATNIK BOARD MEMBER JASON RHODES. OCT. 10, 10-11am @ Brady Auditorium. Come hear Jason Rhodes, a biotech venture capital investor from Atlas Ventures and a Blavatnik Advisory Board member, talk about making a great pitch for funding from the perspective of a grant reviewer. REGISTER HERE.